There has been an update to the guidance document MDCG 2022-4 regarding the appropriate surveillance for legacy devices making use of the transitional provisions under Article 120 of the MDR. As one can expect the changes consists of adjustments all over the document to align it to Regulation (EU) 2023/607 of the European Parliament and of the Council of 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices
The updated guidance document can be accessed using the following link
